Plenary V: Oral Abstract Presentations
Back to course
Video Transcription
Video Summary
Keywords
Dr. Brad Monk
tizodimab vedotin
bevacizumab
pembrolizumab
carboplatin
recurrent cervical cancer
metastatic cervical cancer
response rates
PD-L1 negative patients
so-casolamab
Contact education@igcs.org for assistance.
Powered By